European Medicines Agency - Regulatory - Regulation of medicines

4 - Quality management



    Description

Name

 

EUNETHYDIS - European Network for Hyperkinetic Disorders

Documented adherence to GCP guideline Yes All trials are designed to comply with EU directive 2001/20/EC on clinical trials. Compliance is monitored and no significant problems have arisen when audits have been conducted.
Documented adherence to the ethical considerations for clinical trials in children Yes All projects are passed by local/national ethical bodies and comply with the special ethical requirements for paediatric trials.
Documented adherence to ethical considerations Yes All projects have received Ethical Committee approval and are regularly monitored for compliance.
Availability of Standard Operating Procedures (SOP) Yes See 3.5 In the past most sites determined their own SOPs for single site trials or used those determined by industry sponsors. For the FP7 studies the network is collaborating with the University of Dundee/NHS Tayside Clinical trials Unit and will adopt their SOPs where appropriate and available and collaborate with them in the development/adoption of new SOPs where required.
Capacity to monitor studies
(academic trials industry sponsored trials)
Yes All trials adhere to the monitoring of trials as determined by ICH GCP
Capacity to monitor performance of collaborating centres Yes There is a lead site for each trial/study who take responsibility for implementing monitoring of performance either through a clinical trials unit or via an external CRO.
Quality control and quality assurance, raceability and data safety Yes as in 4.6